5Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth spastic scale of muscle spasticity[J].Phy Ther, 1987,67:206. 被引量：1
6Smith SJ, Ellis E, White S, et al. A double-blind placebo controlled study of botulinum toxin in upper limb spasticity after stroke or head injury[J].Clin Rehabil,2000,79(4):77-84. 被引量：1
7Ubhi T, Bhakta BB, Ives HL, et al. Randomized double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy[J].Arch Dis Child,2000,83:48l-487. 被引量：1
8Koman LA, Brashear A, Rosenfeld S, et al. Botulinum toxin type: a neuromuscular blockade in the treatment of equines foot deformity in cerebral palsy: a multicenter, open-label clinical trial[J].Pediatrics,2000,108(5):1062-1071. 被引量：1
9Bittiger H. Basic aspects of inhibitory transmitter amino acids in spastieity and pain. In Marsden CD ( Ed ). Treating spasticity pharmacological Advances. Hans Huber Pub Toronto., 1980. 20 被引量：1
